report: sanofi eyes investment of up to $1.6-b in germany | anc
Published 4 days ago • 183 plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
21:58
precision medicine in pharma: sanofi’s frank nestle
-
3:00
fda approves biogen-eisai alzheimer’s drug, china in talks to make pfizer paxlovid generic
-
3:51
breaking down the costs of biogen's billion-dollar alzheimer's drug
-
3:31
fda approves controversial biogen alzheimer's drug | dw news
-
1:31
alzheimer's drug decision day: fda to decide on biogen and eisai treatments
-
4:34
homebuyers face double whammy in mortgage rates, low inventory
-
4:51
robotaxis are as much of a risk for tesla as an opportunity, says guggenheim's ronald jewsikow
-
10:58
how germany's universal health-care system works
-
2:56
biogen shares spike after fda approves alzheimer's drug
-
5:53
‘lumpy’ price action ahead for oil and gas prices, says opis forecast
-
3:05
wion fineprint: german media question astrazeneca's efficacy rate | eu | europe | covid-19 vaccine
-
4:32
fda's historic approval of biogen's alzheimer's drug
-
4:51
the global ambitions of healthcare giant fresenius | made in germany
-
13:59
germany: time for a check-up?
-
1:48
biogen reopens following fda approval of company's alzheimer drug
-
2:03
s. korea eyes future growth in global biopharma industry
-
56:19
global projections of dementia: united states, ireland, japan and mexico
-
7:51
swiss-filipino wins science prize for cancer treatment pricing research | the final word
-
1:22
fda recommends biogen's alzheimer's drug for approval
-
8:00
germany's healthcare system is changing in 2022 | what is the e-rezept? do you need it?
-
1:53
fda approves biogen alzheimer's drug, first new therapy for the disease in nearly two decades
-
2:25
sanofi agrees to acquire genzyme for $20.1 billion